Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118388585A enables high-yield amide synthesis with low racemization. Offers supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel Ti-Si catalyst for DPC synthesis via transesterification. High stability, >60% conversion. Cost-effective pharma/polymer intermediate solution.
Patent CN118388585A reveals green visible light catalysis for amide synthesis. Reduces racemization and enhances supply chain reliability for pharmaceutical intermediates globally.
Novel photocatalytic route for SC 69124 ensures high purity and supply continuity. Reduces complexity in pharmaceutical intermediates manufacturing for global partners.
Patent CN112358389A details a green LED-driven synthesis of Vitamin K3 intermediate, offering metal-free production and superior purity for reliable supply chains.
Patent CN107602368B reveals a green two-step method for 2-pentylanthraquinone, offering cost reduction and high purity for hydrogen peroxide manufacturing intermediates.
Patent CN107163073A reveals copper-catalyzed silylation using water. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN114836486B details a novel monooxygenase method for synthesizing chiral beta-amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102465159B details a green microbial route for Eslicarbazepine. Enhance supply chain reliability and reduce manufacturing costs with this scalable biocatalytic technology.
Patent CN102465159B enables green microbial synthesis. Reduces cost and improves supply chain reliability for epilepsy drug intermediates significantly.
Patent CN103936656A details a high-yield Suzuki coupling route. Offers cost reduction and supply chain reliability for optoelectronic and pharma intermediates.
Patent CN103193608A details a high-yield veratraldehyde synthesis route offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN1439643A details a stable spirocyclic bisphosphine ligand offering 99.5% ee and high turnover numbers for efficient pharmaceutical intermediate manufacturing.
Patent CN102268398A reveals a novel nitrilase-based route for Iminodiacetic Acid. Discover cost reduction in glyphosate manufacturing and high-purity supply chain solutions.
Patent CN100400490C details a ligand-free rhodium process for TCD-dialdehyde, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel Oxone-mediated method offers high yield and purity for pharmaceutical intermediates, ensuring cost-effective supply chain solutions.
High-selectivity vanillin intermediate process reduces by-products. Cost-effective supply chain solutions for global flavor and fragrance manufacturers.
Patent CN106222218B reveals green enzymatic route for salidroside. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel catalytic hydrolysis method for 17-hydroxy corticosteroids reducing 21-position byproducts and simplifying purification for reliable API intermediate supply.
Patent CN103255183B details enzymatic asymmetric reduction for high-purity intermediates. Offers significant cost reduction and supply chain reliability for statin synthesis.